amiodarone has been researched along with Adolescent Gynecomastia in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicolas, X | 1 |
| Granier, H | 1 |
| Grippari, JL | 1 |
| Bergez, C | 1 |
| Laborde, JP | 1 |
| Talarmin, F | 1 |
| Antonelli, D | 1 |
| Luboshitzky, R | 1 |
| Gelbendorf, A | 1 |
2 other studies available for amiodarone and Adolescent Gynecomastia
| Article | Year |
|---|---|
[Should drug-induced gynecomastia be monitored?].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Gynecomastia; Humans; Iatroge | 2004 |
Amiodarone-induced gynecomastia.
Topics: Adult; Amiodarone; Gynecomastia; Humans; Male | 1986 |